Fluence Corporation Ltd
ASX:FLC

Watchlist Manager
Fluence Corporation Ltd Logo
Fluence Corporation Ltd
ASX:FLC
Watchlist
Price: 0.097 AUD -2.02% Market Closed
Market Cap: 110.8m AUD

Fluence Corporation Ltd
Investor Relations

Fluence Corp. Ltd. engages in the provision of water treatment solutions. The firm's segments include Operating Units (OUs) and Product and Innovation Group (P&I). Its smart products solutions include Aspiral, NIROBOX and SUBRE. Aspiral is a smart wastewater treatment solution that packages the Company's membrane aerated biofilm reactor technology in standard shipping containers. NIROBOX is a small-footprint, containerized solutions to treat water from any source at any scale. SUBRE upgrades wastewater plants using membrane aerated biofilm reactor modules. Its aerated equipment includes TORNADO Surface Aspirating Aerator, HURRICANE Submersible Aerator, RIPTIDE Direct-Drive Surface Mixer, BREEZE Air Stripper, CYCLONE Coarse Bubble Diffuser, MONSOON Horizontal Surface Aerator and others. The firm primarily focuses on markets including China, the Middle East, Southeast Asia, and North America.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 29, 2025
AI Summary
Q3 2025

Strong Revenue Growth: Year-to-date revenue reached $52.4 million, up 72.9% from the same period in 2024, driven largely by the Ivory Coast Addendum project.

Profitability Improvement: EBITDA for the first three quarters was $1.2 million, up $6.2 million year-to-date compared to 2024, alongside significant cost savings.

Backlog & Bookings: Q3 order bookings were $17.2 million, pushing backlog to $75.7 million, with Q4 expected to be another strong quarter.

Maintained Guidance: Management reaffirmed full-year revenue guidance of $80–95 million and EBITDA of $3–5 million, but expects to finish at the lower end of these ranges.

Margin Dynamics: Gross margin declined to 28.8% year-to-date due to the lower-margin Ivory Coast project, though core business margins are improving.

Positive Cash Flow: Operating cash flow was $2.2 million in Q3 and $7.1 million year-to-date; full-year cash flow is expected to remain positive despite Q4 being negative.

Key Financials
Revenue
$52.4 million
EBITDA
$1.2 million (year-to-date)
Gross Margin
28.8% (year-to-date Q3)
Order Bookings (Q3)
$17.2 million
Order Backlog
$75.7 million (as of September 30)
Operating Cash Flow (Q3)
$2.2 million
Operating Cash Flow (Year-to-date)
$7.1 million
Cash Balance (end Q3)
$14.1 million
SG&A and R&D Costs
$800,000 reduction year-to-date
Earnings Call Recording
Other Earnings Calls

Management

Mr. Thomas M. Pokorsky
CEO & MD
No Bio Available
Mr. Benjamin A. Fash
Chief Financial Officer
No Bio Available
Mr. Spencer D. Smith Esq.
Chief Legal Officer
No Bio Available
Mr. Richard H. Cisterna
Chief Commercial Officer
No Bio Available
Ms. Melanie Jaye Leydin B.Bus, C.A.
Company Secretary
No Bio Available
Ms. Natalya Medinina
VP & Corporate Controller
No Bio Available

Contacts

Address
NEW YORK
10 Bank Street, 8th Floor
Contacts
+12125725700.0
www.fluencecorp.com